However, by upregulating VEGFR2 and improving the recruitment of myeloid-derived suppressor cells, which promotes vascular remodeling and reduces the production of IFN-γ and Th2 cytokines, SOX17 may potentially boost tumor angiogenesis and blood vessel instability [122]. This evidence concerns the gene SOX17 and neoplasm.